Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity

IMPORTANCE: Concerns about the cardiovascular safety of recombinant human growth hormone (rhGH) treatment in childhood have recently been raised; however, long-term studies are limited. OBJECTIVE: To investigate the long-term risk of overall and severe cardiovascular events in patients previously tr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Pediatr
Autors principals: Tidblad, Anders, Bottai, Matteo, Kieler, Helle, Albertsson-Wikland, Kerstin, Sävendahl, Lars
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754074/
https://ncbi.nlm.nih.gov/pubmed/33346824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2020.5199
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars